Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

Industry: #Servicestothe Health Industry

Get AI intraday signals

A.I. Advisor

published Earnings

PLX is expected to report earnings to fall 70.00% to 2 cents per share on May 09

Protalix BioTherapeutics PLX Stock Earnings Reports

Q1'25

Est.

$0.03

Q4'24

Est.

$0.10

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.04

The last earnings report on March 17 showed earnings per share of 10 cents, meeting the estimate of 10 cents. With 1.48M shares outstanding, the current market capitalization sits at 229.42M.

View a ticker or compare two or three

Compare

PLX